Letter: Rauwolfia derivatives and breast cancer.
D001900:Boston; D001943:Breast Neoplasms / Q000139:chemically induced*; D004341:Drug Evaluation; D004739:England; D005069:Evaluation Studies as Topic; D005260:Female; D005387:Finland; D006306:Health Surveys; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008499:Medical Records; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012110:Reserpine / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies
D012110:Reserpine